Payments to Acquire Property, Plant, and Equipment of Artiva Biotherapeutics, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Artiva Biotherapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Artiva Biotherapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $511,000, a 2739% increase year-over-year.
  • Artiva Biotherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $2,587,000, a 303% increase from 2024.
  • Artiva Biotherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $642,000, a 80% decline from 2023.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Artiva Biotherapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,587,000 +$1,945,000 +303% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $642,000 -$2,616,000 -80% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $3,258,000 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY

Artiva Biotherapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $511,000 +$493,000 +2739% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $18,000 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.